Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from NYSE

Tuesday Is Your Last Chance To Buy Alliancebernstein Ntnl Before The Dividend Payout

Tuesday marks the last chance for investors to receive the next dividend payout from Alliancebernstein Ntnl (NYSE:AFB).

Benzinga

Alliancebernstein Glb: Dividend Insights

Tuesday marks the last chance for investors to receive the next dividend payout from Alliancebernstein Glb (NYSE:AWF).

Benzinga

Forum Energy Technologies Earnings Preview

Forum Energy Technologies (NYSE:FET) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Forum Energy Technologies will report an earnings per share (EPS) of $-0.80.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Outlook For Preferred Apartment

Preferred Apartment (NYSE:APTS) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Preferred Apartment will report an earnings per share (EPS) of $-0.65.

Benzinga

Kosmos Energy's Earnings Outlook

Kosmos Energy (NYSE:KOS) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Kosmos Energy will report an earnings per share (EPS) of $0.15.

Benzinga

A Preview Of Darling Ingredients's Earnings

Darling Ingredients (NYSE:DAR) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Darling Ingredients will report an earnings per share (EPS) of $0.88.

Benzinga

Earnings Outlook For Verso

Verso (NYSE:VRS) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Verso will report an earnings per share (EPS) of $0.66.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Analyst Ratings For Gap

Over the past 3 months, 6 analysts have published their opinion on Gap (NYSE:GPS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Earnings Preview For Tegna

Tegna (NYSE:TGNA) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Tegna will report an earnings per share (EPS) of $0.55.

Benzinga

INDYCAR Driver & NASCAR Champion Jimmie Johnson Joins cbdMD As Brand Ambassador

cbdMD, Inc. (NYSE: YCBD) (NYSE: YCBDPA) has entered into an endorsement agreement with 7-time NASCAR Cup Series (NCS) Champion and current NTT INDYCAR SERIES driver Jimmie Johnson as a strategic brand ambassador in the marketplace

Benzinga

Expert Ratings For Carvana

Analysts have provided the following ratings for Carvana (NYSE:CVNA) within the last quarter:

Benzinga

Analyst Ratings For Dell Technologies

Dell Technologies (NYSE:DELL) has observed the following analyst ratings within the last quarter:

Benzinga

Rocket Companies CEO Highlights Strong Mortgage Business: 'But We're So Much More Than That'

Despite an environment of rising rates, the housing market remains robust, according to Rocket Companies Inc (NYSE: RKT) CEO Jay Farner.

Benzinga

FDA Approves Eli Lilly's Jardiance In Broader Heart Patient Population

The FDA approved Eli Lilly And Co (NYSE:LLY) and partner Boehringer Ingelheim's drug, Jardiance, for expanded use in reducing the risk of death and hospitalization for all patients with heart failure. Initially approved by the FDA in 2014 for type 2 diabetes patients, the drug's use was expanded last year in some adults living with heart failure…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Bristol Myers' Shares Are Trading Higher Today

Bristol Myers Squibb & Co (NYSE: BMY) has received positive CHMP opinion for Opdivo (nivolumab) plus chemotherapy for first-line treatment of unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma.

Benzinga

Benzinga's Daily Brief On Trending Tickers For Feb. 25, 2022: GameStop, Tesla, AMD And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. The data on the trending tickers is compiled from a list of most-discussed tickers on the popular Reddit forum WallStreetBets.

Benzinga

Recap: Hyatt Hotels Q4 Earnings

Hyatt Hotels (NYSE:H) reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Hyatt Hotels reported an EPS of $-2.78.

Benzinga

Recap: Pinnacle West Capital Q4 Earnings

Pinnacle West Capital (NYSE:PNW) reported its Q4 earnings results on Friday, February 25, 2022 at 08:40 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap: Summit Midstream Partners Q4 Earnings

Summit Midstream Partners (NYSE:SMLP) reported its Q4 earnings results on Friday, February 25, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Summit Midstream Partners reported an EPS of $-2.93.

Benzinga

Recap: Graham Hldgs Q4 Earnings

Graham Hldgs (NYSE:GHC) reported its Q4 earnings results on Friday, February 25, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Gray Television Registers 9% Revenue Decline In Q4 Due To Lack Of Political Advertising Revenue

Gray Television Inc (NYSE:GTN) reported a fourth-quarter FY21 revenue decline of 9% year-on-year to $721 million, beating the consensus of $669.4 million. Broadcasting revenue declined 9% Y/Y to $692 million. The combined local and national broadcast advertising revenue, excluding political advertising revenue (Total Core Revenue), increased by 26% Y/Y, and retransmission consent revenue…

Benzinga

Biohaven Further Deepens Its Neurology Pipeline With Bristol Myers, Knopp Biosciences Deals

Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) has

Benzinga

Diana Shipping: Q4 Earnings Insights

Diana Shipping (NYSE:DSX) reported its Q4 earnings results on Friday, February 25, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Cinemark Q4 Earnings Tops Estimates

Cinemark Holdings Inc (NYSE:CNK) reported fourth-quarter FY21 sales growth of 579% year-on-year, to $666.63 million, beating the consensus of $601.29 million. Some of the company's theatres were closed for a portion of the three months ended December 31, 2020, and there was limited new film content available for the theatres that had reopened.…

Benzinga

11 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

1 … 602 603 604 605

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.